(0.91%) 5 064.20 points
(0.85%) 38 226 points
(1.51%) 15 841 points
(0.24%) $79.14
(0.10%) $2.04
(0.16%) $2 313.40
(0.38%) $26.93
(0.04%) $963.00
(-0.13%) $0.932
(-0.44%) $10.98
(-0.12%) $0.798
(-2.29%) $91.13
0.00% $ 2.34
Live Chart Being Loaded With Signals
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides...
Stats | |
---|---|
Volumen de hoy | 109 244 |
Volumen promedio | 150 793 |
Capitalización de mercado | 94.81M |
EPS | $0 ( 2024-03-04 ) |
Próxima fecha de ganancias | ( $0.0200 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 16.71 |
ATR14 | $0.00700 (0.30%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-17 | Reznick Yehuda | Buy | 29 800 | Common Stock |
2024-04-01 | Reznick Yehuda | Buy | 0 | |
2024-01-30 | Aghion Daniel | Buy | 3 750 | Common Stock |
2024-01-04 | Kidron Miriam | Buy | 295 500 | Common Stock |
2024-01-04 | Kidron Nadav | Buy | 329 000 | Common Stock |
INSIDER POWER |
---|
92.96 |
Last 95 transactions |
Buy: 3 987 636 | Sell: 392 701 |
Volumen Correlación
Oramed Pharmaceuticals Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Oramed Pharmaceuticals Correlación - Moneda/Commodity
Oramed Pharmaceuticals Finanzas
Annual | 2022 |
Ingresos: | $2.70M |
Beneficio Bruto: | $2.70M (100.00 %) |
EPS: | $-0.970 |
FY | 2022 |
Ingresos: | $2.70M |
Beneficio Bruto: | $2.70M (100.00 %) |
EPS: | $-0.970 |
FY | 2021 |
Ingresos: | $2.70M |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-0.780 |
FY | 2020 |
Ingresos: | $2.71M |
Beneficio Bruto: | $2.71M (100.00 %) |
EPS: | $-0.560 |
Financial Reports:
No articles found.
Oramed Pharmaceuticals
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes. It is also developing ORMD-0901, an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes; and a weight loss treatment in the form of an oral leptin capsule. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico